BEKhealth, a leader in AI-powered patient identification and matching technology, is excited to announce a strategic partnership with Areti Health, known for its development of a generative AI Coordinator to dramatically improve patient recruitment and streamline site operations. This partnership establishes an industry leading end-to-end solution that integrates cutting-edge AI technologies to accelerate study timelines and improve patient diversity and access while enhancing site efficiency and patient experience. Through this partnership, BEKhealth will harness the precision of its BEKplatform for Electronic Medical Records (EMR) known to identify ten times more protocol-eligible candidates to appropriate clinical trials. Areti Health’s generative AI Coordinator will complement this by engaging pre-identified patients, prescreening, scheduling visits, and supporting sites through enrollment. This approach boosts the conversion rate to a remarkable 63%.
This synergy will create a seamless workflow for full funnel support ensuring that trials are conducted more proficiently, with greater accuracy, shorter timelines, and lower cost. “BEKhealth provides vital technology for finding the right patient for the right study at the right time. AI Coordinator takes it all the way from there by providing a groundbreaking mechanism for these patients to actually enter clinical trials”, said Dr. Ilya Gluhovsky, founder and chief executive officer of Areti Health. No longer do patients need to go through a complex recruitment workflow consisting of provider visits, phone calls, data collection forms, etc. Those take a long time with many points of failure, where the majority of qualified and potentially interested candidates drop out. By contrast, AI Coordinator offers patients exactly what they need to join a study easily, in minutes, 24/7 and in the process saves research teams a tremendous operational hassle, a win-win for patients, research teams, and sponsors. This approach also works great by focusing outreach and messaging to improve patient diversity while catering to disadvantaged populations and patients with hearing loss, limited mobility, and other issues. Patients can talk to AI Coordinator in over 50 languages just by typing in their language of choice”.
Josh Ransom, co-founder and vice president at BEKhealth, added, “We are thrilled to partner with Areti Health to address one of the biggest challenges in clinical research – patient recruitment and enrollment. Utilizing the BEKplatform researchers are able to detect more protocol-eligible candidates leading to more qualified patients and lower screen fails. With Areti’s AI Coordinator, we ensure that research sites are able to rapidly and efficiently action all the identified candidates on their terms and timelines. By integrating our AI-driven platforms for identifying and recruiting patients, our site network and pharma customers will streamline the recruitment process, improve clinical operations, ensure trial feasibility for sites, and ultimately bring medical innovations to the market faster.
Think about comprehensively prescreening 5 million medical charts from an EMR system using BEK’s technology and then engaging candidates in real-time without coordinator involvement using AI Coordinator. Research coordinators, trial managers, and PI’s will then free their time for running more studies. This solves one of the most glaring impediments to bringing new therapies to market efficiently and significantly derisks studies both financially and operationally.”
This collaboration marks a significant step forward in the use of generative AI in the clinical research industry. Together, BEKhealth and Areti Health are poised to set a new standard for speed, productivity and innovation in clinical trials.
For more information, please visit https://www.bekhealth.com or email info@bekhealth.com
Learn more about Areti Health here: https://www.aretihealth.com